ISABELLA SOSNOVSKY: Open Payments
NPI 1942252507 · PHILA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$753 in 31 payments from 7 companies in 2025. Trend: 2023 $884 · 2024 $698 · 2025 $753
Food & beverage: $753
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $247 |
| Alkermes, Inc. | 8 | $176 |
| ABBVIE INC. | 7 | $151 |
| Otsuka America Pharmaceutical, Inc. | 2 | $58 |
| E.R. Squibb & Sons, L.L.C. | 2 | $54 |
| Janssen Pharmaceuticals, Inc | 1 | $36 |
| Neurocrine BioSciences, Inc. | 1 | $31 |
Products named: CAPLYTA, ARISTADA, VRAYLAR, REXULTI, COBENFY, INVEGA SUSTENNA, INGREZZA.
Industry payments across PA — which companies pay providers there.
